| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $0.19 (Beat by $0.02) |
| EPS GAAP Actual | $0.19 (Beat by $0.02) |
| Revenue Actual | $0.423584B |
| Revenue Surprise | Beat by $423.584M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.11658 |
| EPS GAAP Estimate | $0.11658 |
| Revenue Estimate | $0.389687238B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 1.7 | 33.55 | 1.66829 | 1.74286 | 1 |
| Dec 2028 | 0.96 | 59.42 | 0.93719 | 0.98943 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.14 | -0.02257 | 0.423584B | 20.15% | 38.3M |
| FQ2 2025 (Jun 2025) | 0.2 | 0.02583 | 0.415813B | 21.86% | 34.06M |
| FQ1 2025 (Mar 2025) | 0.13 | 0.13 | 0.355152B | 22.54% | 355.15M |
| FQ4 2024 (Dec 2024) | 0.0315 | 0.0315 | 0.342786B | 25.87% | 342.79M |
| FQ3 2024 (Sep 2024) | 0.11 | 0.11 | 0.338212B | 21.79% | 338.21M |
| FQ2 2024 (Jun 2024) | 0.12 | 0.12 | 0.324918B | 23.09% | 324.92M |
| FQ1 2020 (Mar 2020) | 0 | 0 | 0.0754295B | 100% | 75.43M |
| FQ2 2020 (Jun 2020) | 0 | 0 | 0.0754295B | 100% | 75.43M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.11658
Consensus Revenue Estimates
0.389687238B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.20454 | -- | 0.20094 | 0.21033 | 7 |
| FQ3 2027 (Sep 2027) | 0.29302 | -- | 0.28252 | 0.30095 | 3 |
| FQ2 2027 (Jun 2027) | 0.34798 | -- | 0.33551 | 0.3574 | 5 |
| FQ1 2027 (Mar 2027) | 0.24406 | -- | 0.23531 | 0.25066 | 3 |
| FQ4 2026 (Oct 2026) | 0.19855 | -- | 0.19529 | 0.20334 | 1 |
| FQ3 2026 (Jul 2026) | 0.19777 | 29.21 | 0.19452 | 0.20254 | 1 |
| FQ2 2026 (Jun 2026) | 0.25649 | 22.02 | 0.24998 | 0.26192 | 4 |
| FQ1 2026 (Mar 2026) | 0.11658 | -11.51 | 0.11473 | 0.11782 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.62B | -- | 0.62B | 0.64B | 5 |
| FQ3 2027 (Sep 2027) | 0.6B | -- | 0.58B | 0.61B | 4 |
| FQ2 2027 (Jun 2027) | 0.59B | -- | 0.58B | 0.6B | 6 |
| FQ1 2027 (Mar 2027) | 0.51B | -- | 0.49B | 0.52B | 4 |
| FQ4 2026 (Oct 2026) | 0.47B | -- | 0.46B | 0.48B | 4 |
| FQ3 2026 (Jul 2026) | 0.46B | 8.5 | 0.46B | 0.47B | 4 |
| FQ2 2026 (Jun 2026) | 0.48B | 13.88 | 0.47B | 0.49B | 6 |
| FQ1 2026 (Mar 2026) | 0.39B | 8.86 | 0.38B | 0.39B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.16257 | 0.14 | -0.02257 | -16.12% |
| FQ2 2025 (Jun 2025) | 0.17417 | 0.2 | 0.02583 | 12.92% |
| FQ1 2025 (Mar 2025) | 0.13 | 0.13 | 100% | |
| FQ4 2024 (Dec 2024) | 0.0315 | 0.0315 | 100% | |
| FQ3 2024 (Sep 2024) | 0.11 | 0.11 | 100% | |
| FQ2 2024 (Jun 2024) | 0.12 | 0.12 | 100% | |
| FQ1 2020 (Mar 2020) | 0 | 0 | NAN% | |
| FQ2 2020 (Jun 2020) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.39B | $0.42B | $38.3M | 9.04% |
| FQ2 2025 (Jun 2025) | $0.38B | $0.42B | $34.06M | 8.19% |
| FQ1 2025 (Mar 2025) | $0B | $0.36B | $355.15M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.34B | $342.79M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.34B | $338.21M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.32B | $324.92M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0.08B | $75.43M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0.08B | $75.43M | 100% |